Retinal Neovascularization [clinicaltrials_resource:f1c80f0922d431c6ceb394e7b18be23f]
Krypton-Argon Regression of Neovascularization Study (KARNS) [clinicaltrials:NCT00000153]clinicaltrials:NCT00564148Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT01024998]Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy [clinicaltrials:NCT01102946]clinicaltrials:NCT01494805Squalamine for the Treatment in Proliferative Diabetic Retinopathy [clinicaltrials:NCT01769183]Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina [clinicaltrials:NCT02088151]clinicaltrials:NCT02486484
condition [clinicaltrials_vocabulary:condition]
Krypton-Argon Regression of Neovascularization Study (KARNS) [clinicaltrials:NCT00000153]clinicaltrials:NCT00564148Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT01024998]Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy [clinicaltrials:NCT01102946]Clinical Research on Retinal Neovascularization of Diabetic Retinopathy [clinicaltrials:NCT01229540]clinicaltrials:NCT01306981clinicaltrials:NCT01494805Squalamine for the Treatment in Proliferative Diabetic Retinopathy [clinicaltrials:NCT01769183]clinicaltrials:NCT02033018Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina [clinicaltrials:NCT02088151]clinicaltrials:NCT02486484
condition browse [clinicaltrials_vocabulary:condition-browse]
Krypton-Argon Regression of Neovascularization Study (KARNS) [clinicaltrials:NCT00000153]clinicaltrials:NCT00564148Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) [clinicaltrials:NCT01024998]Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy [clinicaltrials:NCT01102946]Clinical Research on Retinal Neovascularization of Diabetic Retinopathy [clinicaltrials:NCT01229540]clinicaltrials:NCT01306981clinicaltrials:NCT01494805Squalamine for the Treatment in Proliferative Diabetic Retinopathy [clinicaltrials:NCT01769183]clinicaltrials:NCT02033018Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina [clinicaltrials:NCT02088151]clinicaltrials:NCT02486484
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Retinal Neovascularization [clinicaltrials_resource:f1c80f0922d431c6ceb394e7b18be23f]
Bio2RDF identifier
f1c80f0922d431c6ceb394e7b18be23f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f1c80f0922d431c6ceb394e7b18be23f
identifier
clinicaltrials_resource:f1c80f0922d431c6ceb394e7b18be23f
title
Retinal Neovascularization
@en
type
label
Retinal Neovascularization [clinicaltrials_resource:f1c80f0922d431c6ceb394e7b18be23f]
@en
Retinal Neovascularization